Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L02A" (24)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Medroxyprogesterone (L02AB02) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Farlutal
-
T
60 Tablet(s)
115.08
141.55
10 %
Tablets: Medroxyprogesteroni Acetas 500 mg
Pfizer AG
B / SL
FB
G
Leuprorelin (L02AE02) 9 products
WHO-DDD
DrugBank.ca
IP
Eligard 7.5 mg
103.79
129.30
10 %
Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension: Leuprorelini Acetas 7.5 mg
Recordati AG
A / SL
FB
G
IP
Eligard 22.5 mg
311.35
355.05
10 %
Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension: Leuprorelini Acetas 22.5 mg
Recordati AG
A / SL
FB
G
IP
Eligard 45 mg
622.70
693.65
10 %
Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension: Leuprorelini Acetas 45 mg
Recordati AG
A / SL
FB
G
IP
Lucrin Depot
syringe(s)
123.67
150.90
10 %
Injection preparation: Leuprorelini Acetas 3.75 mg
AbbVie AG
A / SL
FB
G
IP
Lucrin Depot 3 Monate
syringe(s)
360.01
407.95
10 %
Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze: Leuprorelini Acetas 11.25 mg
AbbVie AG
A / SL
FB
G
IP
Lucrin Depot 6 Monate
syringe(s)
930.57
1028.45
10 %
Injection preparation: Leuprorelini Acetas 30 mg
AbbVie AG
A / SL
FB
G
IP
Leuprorelin Sandoz 1
Monat
syringe(s)
102.71
128.10
10 %
Implant: Leuprorelinum 3.6 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Leuprorelin Sandoz 3
Monate
syringe(s)
246.51
284.50
10 %
Implant: Leuprorelinum 5 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Leuprorelin Sandoz 1
Monat
3 1 syringe(s)
378.05
461.55
k.A.
Implant: Leuprorelinum 3.6 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Goserelin (L02AE03) 3 products
WHO-DDD
DrugBank.ca
IP
Zoladex LA SafeSystem
syringe(s)
373.44
422.55
10 %
Fertigspritze mit Implantat: Goserelinum 10.8 mg
AstraZeneca AG
A / SL
FB
G
IP
Zoladex SafeSystem
syringe(s)
131.91
159.90
10 %
Fertigspritze mit Implantat: Goserelinum 3.6 mg
AstraZeneca AG
A / SL
FB
G
IP
Zoladex SafeSystem
3 syringe(s)
378.82
428.40
10 %
Fertigspritze mit Implantat: Goserelinum 3.6 mg
AstraZeneca AG
A / SL
FB
G
Triptorelin (L02AE04) 11 products
WHO-DDD
L
IP
Decapeptyl 0,1 mg
7 syringe(s)
45.38
65.75
10 %
Injection solution in prefilled syringe: Triptorelini Acetas Hydricus
Ferring AG
A / SL
FB
G
IP
Pamorelin LA 11.25 mg
320.02
364.45
10 %
poudre et solvant pour reconstitution d'une suspension pour injection: Triptorelinum 11.25 mg
Debiopharm Research &
Manufacturing SA
A / SL
FB
G
IP
Pamorelin LA 3.75 mg
110.49
136.60
10 %
poudre et solvant pour suspension injectable à libération prolongée: Triptorelinum 3.75 mg
Debiopharm Research &
Manufacturing SA
A / SL
FB
G
L
IP
Pamorelin LA 22.5 mg
589.50
657.55
10 %
poudre et solvant pour suspension injectable à libération prolongée: Triptorelinum 22.5 mg
Debiopharm Research &
Manufacturing SA
A / SL
FB
G
L
IP
Salvacyl
292.07
334.05
10 %
poudre et solvant pour suspension injectable à libération prolongée: Triptorelinum 11.25 mg
Debiopharm Research &
Manufacturing SA
B / SL
FB
G
IP
CI
Pamorelin LA 11.25 mg
Set(s)
390.86
465.10
k.A.
poudre et solvant pour reconstitution d'une suspension pour injection: Triptorelinum 11.25 mg
Debiopharm Research &
Manufacturing SA
A
FB
G
IP
CI
Pamorelin LA 3.75 mg
Set(s)
145.01
182.85
k.A.
poudre et solvant pour suspension injectable à libération prolongée: Triptorelinum 3.75 mg
Debiopharm Research &
Manufacturing SA
A
FB
G
IP
Pamorelin LA 22.5 mg
Set(s)
673.42
789.50
k.A.
poudre et solvant pour suspension injectable à libération prolongée: Triptorelinum 22.5 mg
Debiopharm Research &
Manufacturing SA
A
FB
G
IP
Salvacyl
ampoule(s)
348.60
416.60
k.A.
poudre et solvant pour suspension injectable à libération prolongée: Triptorelinum 11.25 mg
Debiopharm Research &
Manufacturing SA
B
FB
G
IP
Decapeptyl Retard
PR
PR
k.A.
Injektionspräparat i.m./s.c.: Triptorelinum 3.75 mg
Ferring AG
FB
G
IP
Decapeptyl Retard
PR
PR
k.A.
Injektionspräparat i.m./s.c.: Triptorelinum 3.75 mg
Ferring AG
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
